Skip to main content
Cardiology Cardiac Emergency

Cardiac Emergency

Cardiac events common in hospitalized older adults with RSV

Acute cardiac events occur in almost a quarter of adults aged 50 years or older who are hospitalized for respiratory syncytial virus infection.

Editor's Choice

Arrhythmia secondary to abiraterone treatment

A man receiving abiraterone for prostate cancer developed severe hypokalemia, which led to polymorphic ventricular tachycardia and cardiac arrest. It is important to consider iatrogenic causes in cases of arrhythmia.

SGLT2 inhibitors show gout prevention benefit over sulfonylureas

30-04-2024 Gout News

SGLT2 inhibitors reduce the risk of incident gout and gout flares in patients with type 2 diabetes and offer cardiovascular benefits, compared with sulfonylureas.

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

New trial results show routine use of a microaxial flow pump reduces all-cause mortality risk among patients with STEMI complicated by cardiogenic shock.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Episode 3: Unravelling resistant hypertension

Why is it so difficult to diagnose and manage?

Resistant hypertension is a difficult to treat and often misunderstood phenomenon that continues to frustrate cardiologists. 

In this episode, Professors Morris Brown and Bryan Williams debate the causes of resistant hypertension and explore novel treatment options.

Prof. Morris Brown
Prof. Bryan Williams

Case Studies

Arrhythmia secondary to abiraterone treatment

A man receiving abiraterone for prostate cancer developed severe hypokalemia, which led to polymorphic ventricular tachycardia and cardiac arrest. It is important to consider iatrogenic causes in cases of arrhythmia.

A CPR-induced subpleural hematoma

Open Access Hematoma Case Study

Development of a pulmonary hematoma in the subpleural area after bystander CPR. Surgical intervention was successful. 

Coronary thrombectomy for a post-op MI after brain tumor resection

Open Access Myocardial Infarction Case Study

How should you react to an acute MI immediately after a craniotomy for tumor resection? Management of such patients requires carefully balancing the competing risks of myocardial ischemia and postoperative bleeding. 

Current Reviews

Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis

Heparin Systematic Review

The recommended protocol for treating ST-segment elevation myocardial infarction (STEMI), as outlined by the National Institute for Health and Care Excellence (NICE) guidelines [ 1 ], involves primary percutaneous coronary intervention (PCI), which …

Targeting cardiomyocyte cell cycle regulation in heart failure

Open Access Heart Failure Review

Heart failure continues to be a significant global health concern, causing substantial morbidity and mortality. The limited ability of the adult heart to regenerate has posed challenges in finding effective treatments for cardiac pathologies.

IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction

Acute myocardial infarction is an important cardiovascular disease worldwide. Although the mortality rate of myocardial infarction (MI) has improved dramatically in recent years due to timely treatment, adverse remodeling of the left ventricle …

Progress of Mitochondrial Function Regulation in Cardiac Regeneration

Heart failure and myocardial infarction, global health concerns, stem from limited cardiac regeneration post-injury. Myocardial infarction, typically caused by coronary artery blockage, leads to cardiac muscle cell damage, progressing to heart …

Webinar | 16-05-2023 | 17:30 (CEST)

Keynote webinar | Spotlight on cardio-oncology

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.

Prof. Rudolf de Boer
Prof. Lorenz Lehmann
Dr. Teresa Lopéz Fernández
Developed by: Springer Medicine

Further Reading

Predictive Value of 5-Methoxytryptophan on Long-Term Clinical Outcome after PCI in Patients with Acute Myocardial Infarction-a Prospective Cohort Study

Open Access Heart Failure Original Article

Cardiac disease is the leading cause of death in both urban and rural residents in China. High long-term mortality is mostly caused by HF and other MACE following AMI [ 1 ]. PCI and guideline-directed medical therapy can reduce the in-hospital …

Targeting cardiomyocyte cell cycle regulation in heart failure

Open Access Heart Failure Review

Heart failure continues to be a significant global health concern, causing substantial morbidity and mortality. The limited ability of the adult heart to regenerate has posed challenges in finding effective treatments for cardiac pathologies.

Continued decline in the incidence of myocardial infarction beyond the COVID-19 pandemic: a nationwide study of the Swedish population aged 60 and older during 2015–2022

Open Access Myocardial Infarction COVID-19

The number of myocardial infarctions declined during the early COVID-19 pandemic but mechanisms behind these declines are poorly understood. COVID-19 infection is also associated with an increased risk of myocardial infarction which could lead to …

Initial experience with a novel stent-based mechanical thrombectomy device for management of acute myocardial infarction cases with large thrombus burden

Open Access Thrombectomy Original Article

The management of patients with acute myocardial infarction (AMI) and large thrombus burden (LTB) remains challenging. Despite the advent of potent antithrombotic regimens, percutaneous coronary intervention (PCI) in AMI cases with LTB often …